REFERENCES
- Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. Blindness and visual impairment in an American urban population. The Baltimore eye survey. Arch Ophthalmol. 1990;108:286–290. doi:10.1001/archopht.1990.01070040138048.
- Negi A, Vernon SA. An overview of the eye in diabetes. J Roy Soc Med. 2003;96:266–272. doi:10.1258/jrsm.96.5.223.
- Shin ES, Sorenson CM, Sheibani N. Diabetes and retinal vascular dysfunction. J Ophthalmic Vis Res. 2014;9:362–373.
- Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, Caldwell RB. Inflammation and diabetic retinal microvascular complications. J Cardio Vasc Dis Res. 2011;2:96–103. doi:10.4103/0975-3583.83035.
- Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud. 2012;9:6–22. doi:10.1900/RDS.2012.9.6.
- Wat N, Wong RL, Wong IY. Associations between diabetic retinopathy and systemic risk factors. Hong Kong Med J. 2016;22:589–599.
- Noyman I, Marikovsky M, Sasson S, et al. Hyperglycemia reduces nitric oxide synthase and glycogen synthase activity in endothelial cells. Nitric Oxide. 2002;7:187–193. doi:10.1016/S1089-8603(02)00106-4.
- Santoro SA, Walsh JJ, Staatz WD, Baranski KJ. Distinct determinants on collagen support alpha 2 beta 1 integrin-mediated platelet adhesion and platelet activation. Cell Regul. 1991;2:905–913. doi:10.1091/mbc.2.3.203.
- Hampton BM, Schwartz SG, Brantley MA Jr, Flynn HW Jr. Update on genetics and diabetic retinopathy. Clin Ophthalmol. 2015;9:2175–2193.
- Yuan D, Yuan D, Liu Q. Association of the receptor for advancedglycation end products gene polymorphisms with diabetic retinopathy in type 2 diabetes: a meta analysis. Ophthalmologica. 2012;227:223–232. doi:10.1159/000335628.
- Hsieh CH, Pei D, Hung YJ, Hsiao FC. Association between retinoid-X receptor-gamma genetic polymorphisms and diabetic retinopathy. Genet Mol Res. 2011;10:3545–3551. doi:10.4238/2011.December.5.4.
- Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5ʹ-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002;51:1635–1639. doi:10.2337/diabetes.51.5.1635.
- Cilensek I, Mankoc S, Petrovic MG, Petrovic D. GSTT1 null genotypeis a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes, whereas GSTM1 null genotype might confer protection against retinopathy. Dis Markers. 2012;32:93–99. doi:10.1155/2012/675628.
- Wang Y, Ng MC, Lee SC, et al. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes. Diabetes Care. 2003;26:2410–2415. doi:10.2337/diacare.26.8.2410.
- Wu JC, Li XH, Peng YD, Wang JB, Tang JF, Wang YF. Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes. J Endocrinol Invest. 2011;34:e343–e348.
- Tian C, Fang S, Du X, Jia C. Association of the C47T polymorphism in SOD2 with diabetes mellitus and diabetic microvascular complications: a meta-analysis. Diabetologia. 2011;54:803–811. doi:10.1007/s00125-010-2040-1.
- Toda N, Nakanishi-Toda M. Nitricoxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res. 2007;26:205–238. doi:10.1016/j.preteyeres.2007.01.004.
- Gong JY, Deng DT, Sun YH. Association of platelet glycoprotein receptor alpha2 beta1 Integrin and glycoproteiniiia gene polymorphisms with diabetic retinopathy: evidence from 3007 subjects. Curr Eye Res. 2015;40:476–483. doi:10.3109/02713683.2014.932386.
- Shafabakhsh R, Aghadavod E, Ghayour‐Mobarhan M, Ferns G, Asemi Z. Role of histone modification and DNA methylation in signaling pathways involved in diabetic retinopathy. J CellPhysiol. 2018;234:1–8.
- Zhong Q, Kowluru RA. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J CellBiochem. 2010;110:1306–1313.
- Matsubara Y, Murata M, Maruyama T, et al. Association between diabetic retinopathy and genetic variations in alpha2 beta1 integrin, a platelet receptor for collagen. Blood. 2000;95:1560–1564.
- Petrovič MG, Hawlina M, Peterlin B, Petrovič D. BglII gene polymorphism of the α2β1 integrin gene is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes. JHum Genet. 2003;48:457–460.
- Afzal N, AH N, Imran M, et al. Association of alpha-2 beta-1 integrin polymorphism with retinopathy in diabetic patients. J Diabetes Metab. 2012;3:1–5. doi:10.4172/2155-6156.1000223.
- Tsai DH, Jiang YD, Wu KD, Tai TY, Chuang LM. Platelet Collagen receptor alpha2 beta1 integrin and glycoprotein IIIaPI (A1/A2) polymorphisms are not associated with nephropathy in type 2 diabetes. Am J Kidney Dis. 2001;38:1185–1190. doi:10.1053/ajkd.2001.29208.
- Cepeda-Nieto AC, Esquivel-Contreras MT, Duran-Iñiguez F, et al. High prevalence of diabetic retinopathy and lack of association with integrin α2 gene polymorphisms in patients with type 2 diabetes from Northeastern Mexico. Exp Ther Med. 2015;10:435–444. doi:10.3892/etm.2015.2520.
- Miyamoto Y, Saito Y, Nakayama M, et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a –786 T>C mutation associated with coronary spastic angina. Human Mol Gen. 2000;9:2629–2637. doi:10.1093/hmg/9.18.2629.
- Zhang MX, Zhang C, Shen YH, et al. Biogenesis of short intronic repeat 27-nucleotide small RNA from endothelial nitric-oxide synthase gene. J Biol Chem. 2008b;283:14685–14693. doi:10.1074/jbc.M801933200.
- Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy. Clin Endocrinol (Oxf). 2008;68:542–546. doi:10.1111/j.1365-2265.2007.03089.x.
- Zhao S, Li T, Zheng B, Zheng Z. Association with diabetic retinopathy susceptibility: A meta-analysis. Ophthalmic Genet. 2012;33:200–207. doi:10.3109/13816810.2012.675398.
- Cilenšek I, Mankoč S, Globočnik PM, Petrovič D. The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus. Mol Biol Rep. 2012;39:7061–7067. doi:10.1007/s11033-012-1537-8.
- de Syllos RW, Sandrim VC, Lisboa HR, Tres GS, Tanus-Santos JE. Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients. Nitric Oxide. 2006;15:417–422. doi:10.1016/j.niox.2006.02.002.
- Uthra S, Raman R, Mukesh BN, et al. Intron 4 VNTR ofendothelial nitric oxide synthase(eNOS) gene and diabetic retino pathy in type2 patients in southern India. Ophthalmic Genet. 2007;28:77–81. doi:10.1080/13816810701209669.
- Santos K G, Crispim D, Canani LH, Ferrugem PT, Gross JL, Roisenberg I. Relationship of endothelial nitric oxide synthase (eNOS) gene polymorphisms with diabetic retinopathy in Caucasians with type 2 diabetes. Ophthalmic Genet. 2012;33:23–27. doi:10.3109/13816810.2011.620057.
- Narne P, Ponnaluri KC, Siraj M, Ishaq M. Association analysis of polymorphismsin genes related to oxidative stress in south indian type2 diabetic patients with retinopathy. Ophthalmic Genet. 2014;37:1–8. doi:10.3109/13816810.2014.895015.
- World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus [M]. Geneva: WHO; 1999.
- Early Treatment Diabetic Retinopathy Study Research Group. ETDRS Report number 9. Early photocoagulation for diabetic retinopathy. Ophthalmology. 1991;98:766–785.
- Wilkinson CP, Ferris 3rd FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677–1682. doi:10.1016/S0161-6420(03)00475-5.
- World Health Organization. Guidelines for the prevention, management and care of diabetes mellitus. Cairo, Egypt: WHO; 2006.
- Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated calls. Nucleic Acids Res. 1988;16:1215. doi:10.1093/nar/16.3.1215.
- Buraczynska M, Ksiazek P, Zaluska W, Nowicka T, Ksiazek A. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol Dial Transplant. 2004;19:2302–2306. doi:10.1093/ndt/gfh077.
- Cruz-González I, Corral E, Sánchez-Ledesma M, Sánchez-Rodríguez A, Martín-Luengo C, González-Sarmiento R. Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study. BMC Cardio Vasc Disord. 2009;9:1–6.
- Taverna MJ, Elgrably F, Selmi H, Selam JL, Slama G. The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy. Nitric Oxide. 2005;13:88–92. doi:10.1016/j.niox.2005.04.004.
- Awata T, Neda T, Iizuka H, et al. Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. Diabetes Care. 2004;27:2184–2190. doi:10.2337/diacare.27.9.2184.
- Ma ZJ, Chen R, Ren HZ, Guo X, Guo J, Chen LM. Association between eNOS 4b/a polymorphism and the risk of diabetic retinopathy in type 2 diabetes mellitus: a meta-analysis. J Diabetes Res. 2014;2014:1–8.
- Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the eNOS gene polymorphismwith plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245:190–193. doi:10.1006/bbrc.1998.8267.
- Zhang MX, Zhang C, Shen YH, et al. Effect of 27 nt small RNA on endothelial nitric-oxide synthase expression. Mol Biol Cell. 2008a;19:3997–4005. doi:10.1091/mbc.e07-11-1186.
- Azmy R, Dawood A, Kilany A, El-Ghobashy Y, Ellakwa AF, El-Daly M. Association analysis of genetic variations of eNOS and α2β1 integrin genes with type 2 diabetic retinopathy. Appl Cli Genet. 2012;5:55–65.
- Cheema BS, Kohli HS, Sharma R, Bhansali A, Khullar M. Endothelial nitric oxide synthase gene polymorphism and type 2 diabetic retinopathy among Asian Indians. Acta Diabetol. 2012;49:481–488. doi:10.1007/s00592-012-0437-7.